WHO ICTRP trial

An observational study to understand markers indicating disease progression in…

ISRCTN49147196 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN49147196
Public title An observational study to understand markers indicating disease progression in dry age-related macular degeneration
Scientific title A Prospective, Observational study for identification of biomarkers of disease progression in Intermediate Age related Macular Degeneration and Geographic Atrophy (PROBE-IGA)
Primary sponsor Moorfields Eye Hospital NHS Foundation Trust
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries England;United Kingdom
Conditions Age-related macular degeneration - intermediate AMD and geographic atrophy Eye Diseases
Interventions This is a prospective, observational study in two cohorts of participants with intermediate age-related macular degeneration (iAMD) or geographic atrophy (GA) in one or both eyes. It aims to recruit 200 eyes with iAMD and GA (100 in each…
Registration date Sep 24, 2025
Target size 200
Secondary IDs Nil known;Nil known;CPMS 58287, IRAS 330679
Registry page isrctn.com

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations